- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05756231
Cultural and Linguistic Adaptation and Normative Study of the Turkish Version of the Free and Cued Selective Reminding Test: 16-Word Version (FCSRT-T) (FCSRT-T)
April 2, 2025 updated by: Jbid DURSUN UNCU, Istanbul University
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish
Study Overview
Detailed Description
As very commonly used for objectifying Alzheimer Disease memory deficits, an adaptive selection of word choices are done for the use of free and cued selective reminding test (FCSRT) procedure in Turkish population.
In this study the validity and reliability of the test to measure memory deficits in persons with memory complaints will be discussed.
Study Type
Interventional
Enrollment (Actual)
285
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34340
- Istanbul University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- having memory complaints
- demanding clinical consultation for the memory complaint
Exclusion Criteria:
- vascular pathology
- extrapyramidal findings
- psychiatric illness
- epilepsy
- cognition affecting drug use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16)
Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists.
The participants are assessed in neurological diagnosis routine.
|
a pencil-paper assessment tool.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validity of translation
Time Frame: once
|
Variances of answers given to each form will be compared to each other to know if they are similar or different.
|
once
|
|
Factor Analyses
Time Frame: once
|
Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.
|
once
|
|
Validity of the ability of the measure to objectify the memory deficit in dementia
Time Frame: once
|
Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia.
The scores of memory test in early and late stages of dementia will be compared to see if they are different.
It's expected to be different.
|
once
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: İ. Hakan Gürvit, Prof. MD., Istanbul University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 5, 2020
Primary Completion (Actual)
December 26, 2024
Study Completion (Actual)
April 2, 2025
Study Registration Dates
First Submitted
January 26, 2023
First Submitted That Met QC Criteria
February 23, 2023
First Posted (Actual)
March 6, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2025
Last Update Submitted That Met QC Criteria
April 2, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/778
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on SIHT-16
-
VA Office of Research and DevelopmentNational Institutes of Health (NIH)CompletedParalysis | Spinal Cord Injury | Tetraplegia | ParaplegiaUnited States
-
Radboud University Medical CenterCompleted
-
Thymon, LLCCompletedHIV InfectionsUnited States
-
Beat AML, LLCRecruitingPreviously Untreated Relapsed Refractory Acute Myeloid LeukemiaUnited States
-
Centocor Ortho Biotech Services, L.L.C.Completed
-
Janssen Research & Development, LLCCompleted
-
Xentria, Inc.CompletedHealthy ParticipantsUnited States
-
Shanghai Zerun Biotechnology Co.,LtdGuangxi Center for Disease Control and PreventionCompletedCervical Intraepithelial Neoplasia | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18
-
CSL LimitedCompleted
-
GlaxoSmithKlineCompletedInfections, PapillomavirusBelgium, United States